Hearing Loss by Week of Gestation and Birth Weight in Very Preterm Neonates

Dommelen, Paula van; Verkerk, P.H.; Straaten, H.L.M. van; Baerts, W.; Weissenbruch, Mirjam von; Duijsters, Carola; Kaam, Anton van; Steiner, Katerina; Vries, Linda S. de; Swarte, Renate; Sprij, Arwen; Lopriori, Enrico; Gavilanes, Antonio W. D.; Bos, Arie

doi:10.1016/j.jpeds.2014.12.041

Cited by 66 publications

(41 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Though prematurity is a common risk factor in our study group, no significant association was found in statistical analysis between prematurity and hearing impairment. This is in contrast to the study by Paula van et al which showed an increase in incidence of hearing impairment with decreasing gestational age(1.2% -7.5% from 31 to 24 weeks) (10) . In our study the incidence of hearing loss in preterm babies is 4.79%.…”

Section: Discussioncontrasting

confidence: 97%

Risk Factors and Prevalence of Hearing Impairment among Neonates in a South Indian Tertiary Neonatal Centre

Nair¹

2018

jmscr

View full text Add to dashboard Cite

Section: Discussioncontrasting

confidence: 97%

Risk Factors and Prevalence of Hearing Impairment among Neonates in a South Indian Tertiary Neonatal Centre

Nair¹

2018

jmscr

View full text Add to dashboard Cite

“…14 Admission to a neonatal intensive care unit is a relevant risk factor; with the prevalence of hearing loss increasing as gestational age and birth weight decrease (1.2–7.5% in premature babies born at 24–31 weeks and 1.4%–4.8% in babies weighing 750–1500 g). 15 Necessary medical interventions (such as assisted ventilation, venous access and aminoglycoside use) while in the neonatal intensive care unit increase the likelihood of hearing loss. Duration of hospitalization of ≥12 days and a history of treatment by high-frequency ventilation have also been identified as independent risk factors for hearing loss in this population.…”

Section: Epidemiologymentioning

confidence: 99%

Congenital hearing loss

Korver

Smith

Camp

et al. 2017

Nat Rev Dis Primers

398

310

View full text Add to dashboard Cite

Congenital hearing loss (hearing loss present at birth) is one of the most prevalent chronic conditions in children. In the majority of developed countries, neonatal hearing-screening programmes enable early detection; early intervention will prevent delays in speech and language development and have long-lasting beneficial effects on social and emotional development and quality of life. A hearing loss diagnosis is usually followed by a search for an underlying aetiology. Congenital hearing loss might be attributed to environmental and prenatal factors, which prevail in low-income settings; congenital infections, particularly cytomegalovirus, are also a common risk factor for hearing loss. Genetic causes probably account for the majority of cases in developed countries; mutations can affect any component of the hearing pathway, in particular inner ear homeostasis (endolymph production and maintenance) and mechano-electrical transduction (conversion of a mechanical stimulus into electrochemical activity). Once the underlying cause of hearing loss is established, it might direct therapeutic decision-making and guide prevention and (genetic) counseling. Management options include specific antimicrobial therapies, surgical treatment of cranio-facial abnormalities and hearing aids. An improved understanding of the pathophysiology and molecular mechanisms underlying hearing loss and increased awareness of recent advances in genetic testing will promote the development of new treatment and screening strategies.

show abstract

“…Preterm infants experience higher rates of respiratory distress syndrome, bronchopulmonary dysplasia, necrotising enterocolitis, kernicterus, hypoglycaemia, periventricular leucomalacia, seizures, intraventricular haemorrhage, cerebral palsy, infections, feeding difficulties, hypoxic ischaemic encephalopathy, retinopathy of prematurity, as well as visual and hearing loss. [5][6][7][8][9][10][11][12][13][14][15][16] Preterm birth and its sequelae can have significant negative psychosocial and financial impacts on families of preterm newborns. [17][18][19][20] While the risks of mortality and morbidity affecting preterm newborns are considerably more frequent at lower gestational ages, 11 late preterm infants (sometimes called 'near-term') still experience significantly higher risks compared with babies born at term.…”

Section: Bmj Global Healthmentioning

confidence: 99%

Antenatal corticosteroids for women at risk of imminent preterm birth in low-resource countries: the case for equipoise and the need for efficacy trials

et al. 2017

View full text Add to dashboard Cite

The scientific basis for antenatal corticosteroids (ACS) for women at risk of preterm birth has rapidly changed in recent years. Two landmark trials—the Antenatal Corticosteroid Trial and the Antenatal Late Preterm Steroids Trial—have challenged the long-held assumptions on the comparative health benefits and harms regarding the use of ACS for preterm birth across all levels of care and contexts, including resource-limited settings. Researchers, clinicians, programme managers, policymakers and donors working in low-income and middle-income countries now face challenging questions of whether, where and how ACS can be used to optimise outcomes for both women and preterm newborns.In this article, we briefly present an appraisal of the current evidence around ACS, how these findings informed WHO’s current recommendations on ACS use, and the knowledge gaps that have emerged in the light of new trial evidence. Critical considerations in the generalisability of the available evidence demonstrate that a true state of clinical equipoise exists for this treatment option in low-resource settings. An expert group convened by WHO concluded that there is a clear need for more efficacy trials of ACS in these settings to inform clinical practice.

show abstract

Hearing Loss by Week of Gestation and Birth Weight in Very Preterm Neonates

Abstract: Gestational age and birth weight quantify the risk of NHL. This information can be used at the individual level for parent counseling and at the population level for medical decision making.

Cited by 66 publications

References 18 publications

Risk Factors and Prevalence of Hearing Impairment among Neonates in a South Indian Tertiary Neonatal Centre

Risk Factors and Prevalence of Hearing Impairment among Neonates in a South Indian Tertiary Neonatal Centre

Congenital hearing loss

Antenatal corticosteroids for women at risk of imminent preterm birth in low-resource countries: the case for equipoise and the need for efficacy trials

Contact Info

Product

Resources

About